|
EIF2S3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.182300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.783500E-02 |
| Normal-vs-Stage2 |
2.945000E-01 |
| Normal-vs-Stage3 |
3.004200E-02 |
| Normal-vs-Stage4 |
6.192300E-02 |
| Stage1-vs-Stage2 |
4.951200E-01 |
| Stage1-vs-Stage3 |
6.722400E-01 |
| Stage1-vs-Stage4 |
8.107400E-01 |
| Stage2-vs-Stage3 |
3.869800E-01 |
| Stage2-vs-Stage4 |
4.734400E-01 |
| Stage3-vs-Stage4 |
9.378000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.989980E-02 |
| Normal-vs-AfricanAmerican |
7.220000E-01 |
| Normal-vs-Asian |
1.069170E-01 |
| Caucasian-vs-AfricanAmerican |
2.071000E-01 |
| Caucasian-vs-Asian |
7.733800E-01 |
| AfricanAmerican-vs-Asian |
3.004800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.2431000000479E-06 |
| Normal-vs-Female |
3.169200E-01 |
| Male-vs-Female |
6.2799765387922E-12 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.553900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.295800E-02 |
| Normal-vs-Age(61-80Yrs) |
7.447700E-02 |
| Normal-vs-Age(81-100Yrs) |
2.745800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.869600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.555000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.077440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.513400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.168020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.444050E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.823800E-01 |
| Classical-VS-Follicular |
1.350020E-01 |
| Classical-VS-Other |
7.904400E-01 |
| Classical-VS-Normal |
5.506200E-02 |
| Tall-VS-Follicular |
1.635350E-01 |
| Tall-VS-Other |
5.364000E-01 |
| Tall-VS-Normal |
5.207600E-01 |
| Follicular-VS-Other |
9.052600E-01 |
| Follicular-VS-Normal |
1.767950E-02 |
| Other-VS-Normal |
3.405800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.044000E-02 |
| Normal-vs-N1 |
2.980600E-03 |
| N0-vs-N1 |
1.042220E-01 |
|
|
